Plans for communicating important protocol amendments to relevant parties (e.g., trial participants, ethical committees) {25}
Protocol amendments will be communicated to investigators through monthly newsletters and monthly all-site team meetings. These amendments will be submitted to the IRB/REBs by the appropriate site investigators and to the central IRB by the EDC. Study participants will not be informed of study amendments given the brief period of study participation. The trials registration at 